Results 141 to 150 of about 14,439 (224)

Ensuring the safe use of biosimilars [PDF]

open access: yes, 2006
Ensuring the Safe Use of Biosimilars The arrival of biosimilars has sparked a debate as to whether the current INN system can guarantee their safe use.
Declerck, Paul
core  

The Economic Value of Biosimilars

open access: yes, 2016
Biosimilars are biologic products that are similar to the reference biological product in physiochemical characteristics, pharmacokinetics, and efficacy and safety.
Simpson, Samantha
core   +1 more source

Biosimilars in diabetic macular edema: Promise, progress, and pitfalls. [PDF]

open access: yesIndian J Ophthalmol
Jain V   +4 more
europepmc   +1 more source

A landscape of sequence variants in 51 commercial antibody therapeutics. [PDF]

open access: yesAntib Ther
Xu G   +8 more
europepmc   +1 more source

Impact of Regional Healthcare Policy Interventions on Biosimilar Use: A 10-year Evaluation of TNFα Inhibitors Utilization in Italy. [PDF]

open access: yesPharmaceut Med
Vitturi G   +40 more
europepmc   +1 more source

Understanding the market dynamics of biosimilars

open access: yes, 2016
Biosimilars represent an attractive market opportunity in the pharmaceutical industry. In order to understand the underlying market dynamics and to identify the success factors of the biosimilars market, a PEST (political, economic, social, technological)
Keßler, M. (Maximilian)   +3 more
core  

Home - About - Disclaimer - Privacy